Background: Earlier studies have documented an association between cytomegalovirus and cognitive impairment, but results have been inconsistent. Few studies have investigated the association of cytomegalovirus and Epstein-Barr virus with cognitive decline longitudinally. Our aim was to examine whether cytomegalovirus and Epstein-Barr virus are associated with cognitive decline in adults. Method: The study sample is from the Finnish Health 2000 Survey (BRIF8901, n = 7112), which is representative of the Finnish adult population. The sample was followed up after 11 years in the Health 2011 Survey. In addition, persons with dementia were identified from healthcare registers. Results: In the Finnish population aged 30 and over, the seroprevalence of cytomegalovirus was estimated to be 84% and the seroprevalence of Epstein-Barr virus 98%. Seropositivity of the viruses and antibody levels were mostly not associated with cognitive performance. In the middle-aged adult group, cytomegalovirus serointensity was associated with impaired performance in verbal learning. However, the association disappeared when corrected for multiple testing. No interactions between infection and time or between the two infections were significant when corrected for multiple testing. Seropositivity did not predict dementia diagnosis. Conclusions: The results suggest that adult levels of antibodies to cytomegalovirus and Epstein-Barr virus may not be associated with a significant decline in cognitive function or with dementia at population level.
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Introduction
Human cytomegalovirus (CMV, also known as human herpesvirus-5, HHV-5) and Epstein-Barr virus (EBV) are among the most common viruses in humans. Both viruses are members of the herpesvirus family and form a lifelong latent infection. CMV and EBV spread mostly through bodily fluids, such as saliva. Primary infections, as well as subsequent virus reactivations, are often asymptomatic or cause only mild symptoms, and therefore most people do not know that they have been infected. However, primary infection or reactivation of the viruses can be potentially life-threatening to immunocompromised persons (Emery, 2001; Hodson et al., 2005) . In addition, primary infection of CMV during pregnancy may cause cognitive impairment, hearing loss or visual impairment to the unborn baby (Dollard et al., 2007) . In Finland, the seroprevalence of CMV was 56% in pregnant women in South-Western Finland (Alanen et al., 2005) , and in another study the seroprevalence in pregnant women was 76% in a low socioeconomic area and 61% in a high socioeconomic area of Helsinki (Mustakangas et al., 2000) . The seroprevalence of EBV has been estimated to be over 90% (Cohen, 2000; Puhakka et al., 2016) . Infections are slightly more prevalent in women and in persons with low socioeconomic status (Cannon et al., 2010; Dowd et al., 2013) .
Two longitudinal studies with approximately 1000 elderly participants found an association between CMV and cognitive decline.
